International experts inform transparent use of algorithms at policy hackathon
Greater algorithmic transparency in the public sector was the focus of a policy hackathon organised by The Forum and the think tank Reform.
Low-cost, disease-detecting biosensors show global health promise
Researchers have developed low-cost, biodegradable biosensors for global health applications in resource-limited settings.
Imperial shapes its role in the UN Climate Change Conference COP26
The whole Imperial community is invited to get involved in a year of action on climate change and biodiversity loss.
Imperial set to lead UK trial of innovative new cancer drug
The trial will assess a promising new drug developed by Imperial scientists, designed to treat multiple myeloma and diffuse large b-cell lymphoma.
2
Professor Tassos Karadimitris to head myeloma research centre at Imperial
Professor Tassos Karadimitris has been appointed as Langmuir Chair and Director of the Hugh and Josseline Langmuir Centre for Myeloma Research.
New handwashing tech could help halt spread of COVID-19 in developing world
A new technology has dramatically increased rates of handwashing in a trial in Tanzania, and could be key to preventing spread of infectious diseases.
4
Route from research to startup begins with finding a market
Imperial’s Techcelerate programme is helping create entrepreneurially-minded researchers with confidence that their ideas have real-world potential.
Hamlyn Symposium on Medical Robotics (20th - 23rd June 2020)
The 13th Annual Hamlyn Symposium on Medical Robotics 2020: ‘Surgery and Beyond’
Imperial pioneers innovation in clean energy sector
Clean energy companies based on Imperial research have received significant recent investments and are helping develop a clean energy economy.
Celebrating ten years of brain tumour research excellence at Imperial
The John Fulcher Molecular Neuro-Oncology Lab has established itself as an international centre of excellence for brain tumour research.
